TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Bone Mineral Density (BMD) increase in lumbar spine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Bone Mineral Density (BMD) increase in hip
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Height loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Craving score AUC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Semi-liquid diet intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative albumin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Risk of death/MI
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of minor bleeding events
Endpoint domain: Adverse events/effects
Primary endpoint: Teeth sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Colour change in shade guide units (SGU)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage change in BMD from baseline to month 36
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Aortic valve calcification increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diastolic Blood Pressure (DBP) improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Preference for SP over DMPA-IM
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: blood volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: intramuscular temperature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cure or improvement of hypertension after PTRA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oxygen delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: ACDC-rTMS-stimulation effects on depression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain reduction during dressing change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain reduction immediately after dressing change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: spinal position sense accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ≥2-fold increase in antibody concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: breast-milk intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain during procedure (PGP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Performance on post test over ocular trauma-related questions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Agreement in circulatory and neurologic examinations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fasting glucose/insulin ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Quantitative insulin-sensitivity check index (QUICKI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Social Interaction problems
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Improved health literacy behaviours
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Improved self-management skills
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Improved perception of companionship, emotional and informational support
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Resource utilization for AF ablation
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: immediate reduction in pain while walking
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: peak hip abduction moment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Performance and Daily Functioning
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Impact of Symptoms: Daily Interference
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: AAQoL total score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: incremental cost per extra successful follow-up
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: serum 25‐OHD levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median B cell count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Median natural killer cell count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Proportion of patients with detectable CMV and EBV DNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Cardiac deaths associated with ARC definite ST
Endpoint domain: Mortality/survival
Primary endpoint: Cardiac deaths associated with ARC-like definite GO
Endpoint domain: Mortality/survival
Primary endpoint: Carotid artery puncture
Endpoint domain: Adverse events/effects
Primary endpoint: NFT (Time to establish airway)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Time to first ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: subsequent donations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: severe PVD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Transient desaturation and apnea
Endpoint domain: Adverse events/effects
Primary endpoint: improvement of speech
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: increase in BDNF concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: occurrence rate of post-ERCP pancreatitis
Endpoint domain: Adverse events/effects
Primary endpoint: 30-day cardiac death
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of postoperative ALI/ARDS
Endpoint domain: Adverse events/effects
Primary endpoint: VAS assessment of burning
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: unplanned hospitalization rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: ratio of ADP/TRAP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Boston Symptom Severity Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional Status Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Energy Availability (EA) in the late postprandial period
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Metabolic rate in the late postprandial period
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rate of clinical failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Initial resolution of symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sustained resolution of symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of autoreactive VH4.34 memory B cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Time on the PWC150 test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvements in health and well-being on the Body Cathexis Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Interrater reliability of outcome measures
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Calcium intake difference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total daily oral calorie intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rate of tendon healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median postoperative PENN total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage change in patient satisfaction scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Intervention reach
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Fidelity of implementation
Endpoint domain: Adverse events/effects
Primary endpoint: Behaviour change
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Fatal crashes
Endpoint domain: Mortality/survival
Primary endpoint: Visible injuries per 100 crashes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of sensitivity pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Timing of allergic reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Positive provocation tests
Endpoint domain: Adverse events/effects
Primary endpoint: Decline of HCV-RNA level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Healing of refractory duodenal ulcers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: composite strength score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: needle repositionings
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: bone contacts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: physician comfort
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Effectiveness of CBT and counselling compared to GP care
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in synovial fluid concentrations of SP and IL-6
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Complete virological and histological responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: CushingQOL scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Treatment adherence measured by the Morisky‐Green test
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean Lobene composite scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Extent and intensity scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: combined outcome of death or major disability at 2 years of age
Endpoint domain: Mortality/survival
Primary endpoint: Urinary total cortisol metabolites (TCM) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: maximal horizontal-force production
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mechanical effectiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 5-m and 20-m sprint performance improvements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lactate levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Pressure pain thresholds
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Intercourse success rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Global assessment question
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Reduction of visual analog scale composite score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Regional control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in community perception on bilharzia
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Verbal memory functioning
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Total medical costs for treatment-related ERCP
Endpoint domain: Resource use
Primary endpoint: Rate of diverticulitis recurrence
Endpoint domain: Mortality/survival
Primary endpoint: TnT levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fibrinogen levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of joint pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CS-PFP10 total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: upper and lower muscle strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in spinal BMD (BMDLS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in femoral BMD (BMDF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Geometric mean titers (GMTs) of antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: HBGA-blocking antibody titers of ≥200
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: time to pass flatus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Mean serum vitamin B12 improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Pain during light treatment
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Modified Medical Research Council Dyspnoea Scale improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Effective rates of depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Effective rates of anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: General attitudes towards caring for the elderly
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Medical student attitudes towards home care training
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Knowledge of geriatrics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CRP, SAA, and fibrinogen values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: median motor nerve distal latencies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: relaxation scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: microbiologically documented infections
Endpoint domain: Adverse events/effects
Primary endpoint: bacteremias
Endpoint domain: Adverse events/effects
Primary endpoint: CFS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Function Questionnaire responses
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Adverse events with Fresnel prisms
Endpoint domain: Adverse events/effects
Primary endpoint: Atrial uptake of (‐) perhexiline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incident STI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: overall satisfaction with treatment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Exposure of (S)-(S)-(+)‐α‐benidipine and (R)-(R)-(−)‐α‐benidipine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood pressure-lowering effect
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: number of ruptures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: stages of rupture resolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TNF‐α reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: DAS28‐CRP < 2.6 achievement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cross-sectional area of type I fibers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Cross-sectional area of type IIa fibers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Wpeak improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of pulmonary exacerbations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 24-hour sputum production
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lung function decline (forced expiratory volume)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Decrease in SRF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: durations of peak effect
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: durations of clinical action
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of readmission
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Days of rehospitalization
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Medication changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean relative bioavailability of functional C1‐INH
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean half‐life of functional C1‐INH
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of injection site reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Heart rate (HR; bpm)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Heart rate variability (HRV; R-R, pNN50, LF, HF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Preference for hypo-osmotic saline drops
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Dryness and lens awareness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Contact lens osmolality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain during epidural placement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for additional local anesthetic infiltration
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Patient and graft survival at 3 months
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of primary graft nonfunction
Endpoint domain: Adverse events/effects
Primary endpoint: Incremental cost-effectiveness ratio for eptifibatide therapy
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Estimated life expectancy
Endpoint domain: Mortality/survival
Primary endpoint: Cost-utility ratio for eptifibatide
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: SGRQ (St. George's Respiratory Questionnaire)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of symptomatic episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neurocognitive functioning
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: peripheral edema
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Iron status improvement (ferritin to c-reactive protein ratios)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Liver damage marker changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of episodes of acute AR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of life (Visual Analogue Scale)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Metabolite profiling analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: mean verbal response scale pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean IV morphine equivalent dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progression of joint damage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean 'off' time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Responder rates (>=30%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 'On' time without dyskinesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Aortic augmentation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: median percentage reduction in bacterial contamination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Immediate hemostasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success rate of anesthetic efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes